GGrantIndex
← Leaderboards

David G Maloney

Fred Hutchinson Cancer Research Center

$3,575,748
Attributed
$3,575,748
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $263.7K · FY200518
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$3,575,748 · 4

By mechanism

P01$2,794,363 · 3
R01$781,385 · 1

Top collaborators

No co-investigators on record.

Most similar at Fred Hutchinson Cancer Research Center

Same institution · by research overlap

Others in their field

Top investigators on “Tumor

Research focus

TumorConditioningTransplantationEngraftmentAntibodiesDoseRelapseToxic EffectHematopoieticFludarabineAllogenicProliferatingAutologousNatural ImmunosuppressionChimerismAllograftingHigh RiskImmunologicsPeripheral Blood Stem CellGraft Vs Tumor EffectCellsGrantMortality Vital StatisticsCsf3 Gene

Grant awards (18)

Project 3: Stem Cell Allografts for Lymphoid Malignancies$122,776
P01 · FY2018 · CA · contact PI
Project 3: Stem Cell Allografts for Lymphoid Malignancies$257,616
P01 · FY2017 · CA · contact PI
Project 3: Stem Cell Allografts for Lymphoid Malignancies$257,616
P01 · FY2016 · CA · contact PI
Project 3: Stem Cell Allografts for Lymphoid Malignancies$257,616
P01 · FY2015 · CA · contact PI
Project 3: Stem Cell Allografts for Lymphoid Malignancies$263,671
P01 · FY2014 · CA · contact PI
Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations$176,157
P01 · FY2013 · CA · contact PI
Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations$182,361
P01 · FY2012 · CA · contact PI
Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations$184,831
P01 · FY2011 · CA · contact PI
Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations$185,605
P01 · FY2010 · CA · contact PI
Allogeneic HCT for Hematologic Malignancies: Pharmacologic Manipulations$222,005
P01 · FY2009 · CA · contact PI
Mixed Chimerism in the Treatment of B-Cell Malignancies$193,569
P01 · FY2008 · CA · contact PI
Mixed Chimerism in the Treatment of B-Cell Malignancies$191,797
P01 · FY2007 · CA · contact PI
Mixed Chimerism in the Treatment of B-Cell Malignancies$102,539
P01 · FY2006 · CA · contact PI
Mixed Chimerism in the Treatment of B-Cell Malignancies$99,552
P01 · FY2005 · CA
Mixed Chimerism in the Treatment of B-Cell Malignancies$96,652
P01 · FY2004 · CA
ANTI-CD20 ANTIBODY THERAPY OF NHL-- MECHANISM OF ACTION$268,197
R01 · FY2002 · CA
ANTI-CD20 ANTIBODY THERAPY OF NHL-- MECHANISM OF ACTION$260,387
R01 · FY2001 · CA
ANTI-CD20 ANTIBODY THERAPY OF NHL-- MECHANISM OF ACTION$252,801
R01 · FY2000 · CA